New York: 20:35 || London: 01:35 || Mumbai: 05:05 || Singapore: 07:35

Recommendations » UK

ProStrakan (LON:PSK) report: Norgine acquires stake in ProStrakan

November 9, 2010, Tuesday, 19:37 GMT | 14:37 EST | 00:07 IST | 02:37 SGT
Contributed by Daniel Stewart & Company


By Daniel Stewart & Co

 

- Norgine B.V. announced that it has acquired 25,515,873 shares in ProStrakan Group plc representing 12.6 per cent. of the issued share capital of ProStrakan.


- Whilst Norgine will continue to consider its options in relation to its holding in ProStrakan, it confirms that it has no current intention to make an offer for the company.


- Founded in 1906, and head-quartered in Amsterdam, Norgine is a specialty pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products.


- The company has a strong pan-European presence.